A Study of TY-302 in Patients With Advanced Solid Tumors
Clinical trial NCT04433494 · UNKNOWN
Trial details
- NCT number
- NCT04433494
- Sponsor
- TYK Medicines, Inc
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-07
- Primary completion
- 2023-05-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.